Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8W2U

Cryo-EM structure of human tankyrase 2 SAM-PARP filament -apo state (consensus map).

Summary for 8W2U
Entry DOI10.2210/pdb8w2u/pdb
Related8W23 8W25 8W27 8W28
EMDB information43759
DescriptorPoly [ADP-ribose] polymerase tankyrase-2, ZINC ION (2 entities in total)
Functional Keywordsnad+ adp-ribosyltransferase, wnt signaling, inhibitor, signaling protein, signaling protein-inhibitor complex, signaling protein/inhibitor
Biological sourceHomo sapiens (human)
Total number of polymer chains20
Total formula weight714454.98
Authors
Malone, B.F.,Zimmerman, J.L.,Dow, L.E.,Hite, R.K. (deposition date: 2024-02-21, release date: 2025-07-09)
Primary citationZimmerman, J.,Malone, B.F.,Finkin-Groner, E.,Sun, S.,Liang, R.,Foronda, M.,Schatoff, E.M.,Granowsky, E.,Goswami, S.,Katti, A.,Leach, B.,Alcorn, H.,Tammela, T.,Fukase, Y.,Khan, T.,Huggins, D.J.,Ginn, J.,Liverton, N.,Hite, R.K.,Dow, L.E.
A potent and selective TNKS2 inhibitor for tumor-selective WNT suppression.
Biorxiv, 2025
Cited by
PubMed Abstract: Hyperactive WNT signaling is a potent cancer driver, but clinical translation of WNT inhibitors has been hampered by on-target toxicities. WNT signaling can be constrained through inhibition of the PARP family enzymes Tankyrase 1 (TNKS1) and Tankyrase 2 (TNKS2), however, existing TNKS inhibitors suppress WNT signaling in both tumor and healthy tissues. In this study, we show that the loss of chromosome 8p that occurs in approximately half of advanced epithelial malignancies, creates a collateral vulnerability that enables tumor-selective inhibition of Tankyrase activity. 8p loss depletes expression of TNKS1 and creates a tumor-specific dependency on the functionally redundant TNKS2 protein. Through structure-guided drug design, we identify a first-in-class TNKS2-selective inhibitor that can drive selective WNT inhibition in TNKS1-deficient oncogenic cell and organoid models. This work demonstrates a targetable vulnerability in multiple cancer types, providing a new approach to potent and selective WNT-targeted therapies.
PubMed: 40093088
DOI: 10.1101/2025.03.04.641305
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.46 Å)
Structure validation

238582

数据于2025-07-09公开中

PDB statisticsPDBj update infoContact PDBjnumon